Ionis Pharmaceuticals Inc
IONSNasdaqCIK 874015HealthcareFiscal year ends Dec 31
Reports and events: 346 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2313:41 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-040631 |
| 2026-10-2120:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-040388 |
| 2026-09-2310:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-037371 |
| 2026-09-0421:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-035802 |
| 2026-09-0410:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-035657 |
| 2026-07-2921:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000874015-26-000251 |
| 2026-07-2911:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-029960 |
| 2026-07-1001:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-028154 |
| 2026-07-0918:55 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-028092 |
| 2026-06-2419:48 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-026232 |
| 2026-06-1218:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-025050 |
| 2026-06-0816:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-024407 |
| 2026-05-2816:41 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-023093 |
| 2026-04-2918:33 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000874015-26-000177 |
| 2026-04-2911:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-017637 |
| 2026-04-2320:21 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001140361-26-016388 |
| 2026-04-2111:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-015801 |
| 2026-03-0911:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-008340 |
| 2026-02-2621:25 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000874015-26-000115 |
| 2026-02-2512:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-006718 |
| 2026-01-1212:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-000893 |
| 2026-01-0711:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-000435 |
| 2025-11-1721:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-284609 |
| 2025-11-1011:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-041225 |
| 2025-11-0322:17 ET | 8-K/A | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-040220 |
| 2025-10-2920:43 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000874015-25-000266 |
| 2025-10-2911:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-039650 |
| 2025-09-2211:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-035634 |
| 2025-09-0211:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-033541 |
| 2025-08-2118:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-032176 |
| 2025-07-3019:56 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000874015-25-000167 |
| 2025-07-3015:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-027949 |
| 2025-06-1213:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-022267 |
| 2025-06-1010:02 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-25-022001 |
| 2025-05-1911:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-019620 |
| 2025-04-3019:56 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000874015-25-000123 |
| 2025-04-3015:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-016562 |
| 2025-04-2520:25 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0001140361-25-015771 |
| 2025-03-1200:38 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-008178 |
| 2025-02-1921:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000874015-25-000089 |
| 2025-02-1916:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-005080 |
| 2024-12-2019:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-050057 |
| 2024-11-0621:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000874015-24-000232 |
| 2024-11-0616:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-045370 |
| 2024-09-1222:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-217333 |
| 2024-09-0920:33 ET | 8-K | 8.01 Other events | 0001193125-24-215939 |
| 2024-08-0120:57 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000874015-24-000187 |
| 2024-08-0115:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-035233 |
| 2024-06-1813:29 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-24-030447 |
| 2024-06-1020:33 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-029588 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.